Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Interchangeable Biosimilars May Qualify For ‘Immediate Substitution’ In Medicare Part D
Dec 21 2022
•
By
Cathy Kelly
Immediate Substitution Not Allowed For Non-Interchangeable Biosimilars • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
More from Biosimilars
More from Products